keyword
https://read.qxmd.com/read/38589016/%C3%AE-synuclein-a-promising-biomarker-for-parkinson-s-disease-and-related-disorders
#21
JOURNAL ARTICLE
Taku Hatano, Ayami Okuzumi, Gen Matsumoto, Tsunemi Taiji, Nobutaka Hattori
Mutations in the SNCA gene, which encodes α-synuclein (α-syn), play a key role in the development of genetic Parkinson's disease (PD). α-Syn is a major component of Lewy bodies in PD and glial cytoplasmic inclusions in multiple system atrophy (MSA). Rapid eye movement sleep behavior disorder (RBD) patients often progress to PD, dementia with Lewy bodies (DLB), or MSA, collectively known as α-synucleinopathies. The loss of dopaminergic neurons with Lewy bodies precedes motor dysfunction in these diseases, but the mechanisms of neurodegeneration due to α-syn aggregation are poorly understood...
April 9, 2024: Journal of Movement Disorders
https://read.qxmd.com/read/38585816/a-resistance-evading-antibiotic-for-treating-anthrax
#22
Dallas Hughes, William Lawrence, Jennifer Peel, de Winter Rosan, Losee Ling, Nitti Niiti, Peoples Aaron, Rhythm Shukla, Harold MacGillavry, Henry Heine, Hensel Martha, Whorton Elbert, Markus Weingarth, Kim Lewis
The antimicrobial resistance crisis (AMR) is associated with millions of deaths and undermines the franchise of medicine. Of particular concern is the threat of bioweapons, exemplified by anthrax. Introduction of novel antibiotics helps mitigate AMR, but does not address the threat of bioweapons with engineered resistance. We reasoned that teixobactin, an antibiotic with no detectable resistance, is uniquely suited to address the challenge of weaponized anthrax. Teixobactinbinds to immutable targets, precursors of cell wall polymers...
March 25, 2024: Research Square
https://read.qxmd.com/read/38584319/associations-between-multimorbidity-and-neuropathology-in-dementia-consideration-of-functional-cognitive-disorders-psychiatric-illness-and-dementia-mimics
#23
JOURNAL ARTICLE
Calum A Hamilton, Fiona E Matthews, Johannes Attems, Paul C Donaghy, Daniel Erskine, John-Paul Taylor, Alan J Thomas
BACKGROUND: Multimorbidity, the presence of two or more health conditions, has been identified as a possible risk factor for clinical dementia. It is unclear whether this is due to worsening brain health and underlying neuropathology, or other factors. In some cases, conditions may reflect the same disease process as dementia (e.g. Parkinson's disease, vascular disease), in others, conditions may reflect a prodromal stage of dementia (e.g. depression, anxiety and psychosis). AIMS: To assess whether multimorbidity in later life was associated with more severe dementia-related neuropathology at autopsy...
April 8, 2024: British Journal of Psychiatry
https://read.qxmd.com/read/38583969/-blood-biomarker-of-lewy-body-disease
#24
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
2024: Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
https://read.qxmd.com/read/38583888/a-second-chance-for-a-new-heart-the-role-of-metabolic-and-bariatric-surgery-in-patients-with-end-stage-heart-failure
#25
JOURNAL ARTICLE
Deanna L Palenzuela, Divyansh Agarwal, Karen Flanders, Erin Coglianese, Lana Tsao, David D'Alessandro, Gregory D Lewis, Michael Fitzsimons, Denise Gee
BACKGROUND: Obesity is an independent risk factor for heart failure (HF). Substantial weight loss has been shown to reverse obesity-related cardiomyopathy. This study aimed to report our institution's experience with laparoscopic sleeve gastrectomy (LSG) in patients with morbid obesity and end-stage HF. METHODS: Between 2018 and 2022, 26 patients with end-stage HF were referred for LSG. Of 26 patients, 16 underwent an operation, and 10 did not. After institutional review board approval, a retrospective electronic medical record review was performed to evaluate (i) age, (ii) preoperative weight, (iii) decrease in body mass index (BMI) score, (iv) whether the patient underwent heart transplantation, and (v) mortality...
April 2024: Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38581586/altered-tfeb-subcellular-localization-in-nigral-neurons-of-subjects-with-incidental-sporadic-and-gba-related-lewy-body-diseases
#26
JOURNAL ARTICLE
Tim E Moors, Martino L Morella, Cesc Bertran-Cobo, Hanneke Geut, Vinod Udayar, Evelien Timmermans-Huisman, Angela M T Ingrassia, John J P Brevé, John G J M Bol, Vincenzo Bonifati, Ravi Jagasia, Wilma D J van de Berg
Transcription factor EB (TFEB) is a master regulator of genes involved in the maintenance of autophagic and lysosomal homeostasis, processes which have been implicated in the pathogenesis of GBA-related and sporadic Parkinson's disease (PD), and dementia with Lewy bodies (DLB). TFEB activation results in its translocation from the cytosol to the nucleus. Here, we investigated TFEB subcellular localization and its relation to intracellular alpha-synuclein (aSyn) accumulation in post-mortem human brain of individuals with either incidental Lewy body disease (iLBD), GBA-related PD/DLB (GBA-PD/DLB) or sporadic PD/DLB (sPD/DLB), compared to control subjects...
April 6, 2024: Acta Neuropathologica
https://read.qxmd.com/read/38581545/peripheral-immune-profile-in-drug-na%C3%A3-ve-dementia-with-lewy-bodies
#27
JOURNAL ARTICLE
Tadashi Umehara, Masahiro Mimori, Tatsushi Kokubu, Masakazu Ozawa, Tomotaka Shiraishi, Takeo Sato, Asako Onda, Hiromasa Matsuno, Shusaku Omoto, Renpei Sengoku, Hidetomo Murakami, Hisayoshi Oka, Yasuyuki Iguchi
BACKGROUND: Accumulating evidence suggests that peripheral inflammation is associated with the pathogenesis of Parkinson's disease (PD). We examined peripheral immune profiles and their association with clinical characteristics in patients with DLB and compared these with values in patients with PD. METHODS: We analyzed peripheral blood from 93 participants (drug-naïve DLB, 31; drug-naïve PD, 31; controls, 31). Absolute leukocyte counts, absolute counts of leukocyte subpopulations, and peripheral blood inflammatory indices such as neutrophil-to-lymphocyte ratio were examined...
April 6, 2024: Journal of Neurology
https://read.qxmd.com/read/38581050/disease-and-brain-region-specific-immune-response-profiles-in-neurodegenerative-diseases-with-pure-and-mixed-protein-pathologies
#28
JOURNAL ARTICLE
Tim Bathe, Gabriela P Hery, Jonathan A B Villareal, Jennifer L Phillips, Eric M Cohen, Rohan V Sharma, Wangchen Tsering, Stefan Prokop
The disease-specific accumulation of pathological proteins has long been the major focus of research in neurodegenerative diseases (ND), including Alzheimer's disease (AD) and related dementias (RD), but the recent identification of a multitude of genetic risk factors for ND in immune-associated genes highlights the importance of immune processes in disease pathogenesis and progression. Studies in animal models have characterized the local immune response to disease-specific proteins in AD and ADRD, but due to the complexity of disease processes and the co-existence of multiple protein pathologies in human donor brains, the precise role of immune processes in ND is far from understood...
April 5, 2024: Acta Neuropathologica Communications
https://read.qxmd.com/read/38580194/midbrain-organoids-for-parkinson-s-disease-pd-a-powerful-tool-to-understand-the-disease-pathogenesis
#29
REVIEW
Harysh Winster Suresh Babu, Sindduja Muthu Kumar, Harsimrat Kaur, Mahalaxmi Iyer, Balachandar Vellingiri
Brain Organiods (BOs) are a promising technique for researching disease progression in the human brain. These organoids, which are produced from human induced pluripotent stem cells (HiPSCs), can construct themselves into structured frameworks. In the context of Parkinson's disease (PD), recent advancements have been made in the development of Midbrain organoids (MBOs) models that consider key pathophysiological mechanisms such as alpha-synuclein (α-Syn), Lewy bodies, dopamine loss, and microglia activation...
April 3, 2024: Life Sciences
https://read.qxmd.com/read/38578903/automated-capillary-electrophoresis-immunoblot-for-the-detection-of-alpha-synuclein-in-mouse-tissue
#30
JOURNAL ARTICLE
Leonie Erdmann, Patrícia I Santos, Petra Rieper, Hans W Klafki, Dirk Beutner, Jens Wiltfang, Tiago F Outeiro, Cristian Setz
BACKGROUND: Alpha-synuclein (aSyn) is a key player in neurodegenerative diseases such as Parkinson's disease (PD), dementia with Lewy bodies, or multiple system atrophy. aSyn is expressed throughout the brain, and can also be detected in various peripheral tissues. In fact, initial symptoms of PD are non-motoric and include autonomic dysfunction, suggesting that the periphery might play an important role in early development of the disease. aSyn is expressed at relatively low levels in non-central tissues, which brings challenges for its detection and quantification in different tissues...
April 5, 2024: Journal of Parkinson's Disease
https://read.qxmd.com/read/38576865/joint-tissue-integrative-analysis-identifies-high-risk-genes-for-parkinson-s-disease
#31
JOURNAL ARTICLE
Ya-Shi Wu, Wen-Han Zheng, Tai-Hang Liu, Yan Sun, Yu-Ting Xu, Li-Zhen Shao, Qin-Yu Cai, Ya Qin Tang
The loss of dopaminergic neurons in the substantia nigra and the abnormal accumulation of synuclein proteins and neurotransmitters in Lewy bodies constitute the primary symptoms of Parkinson's disease (PD). Besides environmental factors, scholars are in the early stages of comprehending the genetic factors involved in the pathogenic mechanism of PD. Although genome-wide association studies (GWAS) have unveiled numerous genetic variants associated with PD, precisely pinpointing the causal variants remains challenging due to strong linkage disequilibrium (LD) among them...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38570511/influences-of-amyloid-%C3%AE-and-tau-on-white-matter-neurite-alterations-in-dementia-with-lewy-bodies
#32
JOURNAL ARTICLE
Elijah Mak, Robert I Reid, Scott A Przybelski, Timothy G Lesnick, Christopher G Schwarz, Matthew L Senjem, Sheelakumari Raghavan, Prashanthi Vemuri, Clifford R Jack, Hoon Ki Min, Manoj K Jain, Toji Miyagawa, Leah K Forsberg, Julie A Fields, Rodolfo Savica, Jonathan Graff-Radford, David T Jones, Hugo Botha, Erik K St Louis, David S Knopman, Vijay K Ramanan, Dennis W Dickson, Neill R Graff-Radford, Tanis J Ferman, Ronald C Petersen, Val J Lowe, Bradley F Boeve, John T O'Brien, Kejal Kantarci
Dementia with Lewy bodies (DLB) is a neurodegenerative condition often co-occurring with Alzheimer's disease (AD) pathology. Characterizing white matter tissue microstructure using Neurite Orientation Dispersion and Density Imaging (NODDI) may help elucidate the biological underpinnings of white matter injury in individuals with DLB. In this study, diffusion tensor imaging (DTI) and NODDI metrics were compared in 45 patients within the dementia with Lewy bodies spectrum (mild cognitive impairment with Lewy bodies (n = 13) and probable dementia with Lewy bodies (n = 32)) against 45 matched controls using conditional logistic models...
April 3, 2024: NPJ Parkinson's Disease
https://read.qxmd.com/read/38568475/characterization-of-monoamine-oxidase-b-mao-b-as-a-biomarker-of-reactive-astrogliosis-in-alzheimer-s-disease-and-related-dementias
#33
JOURNAL ARTICLE
Methasit Jaisa-Aad, Clara Muñoz-Castro, Molly A Healey, Bradley T Hyman, Alberto Serrano-Pozo
Reactive astrogliosis accompanies the two neuropathological hallmarks of Alzheimer's disease (AD)-Aβ plaques and neurofibrillary tangles-and parallels neurodegeneration in AD and AD-related dementias (ADRD). Thus, there is growing interest in developing imaging and fluid biomarkers of reactive astrogliosis for AD/ADRD diagnosis and prognostication. Monoamine oxidase-B (MAO-B) is emerging as a target for PET imaging radiotracers of reactive astrogliosis. However, a thorough characterization of MAO-B expression in postmortem control and AD/ADRD brains is lacking...
April 3, 2024: Acta Neuropathologica
https://read.qxmd.com/read/38564875/catatonia-in-patients-with-dementia-a-descriptive-study-of-clinical-profiles-and-treatment-response
#34
JOURNAL ARTICLE
Vanina Ramognino, Thomas Fovet, Mathilde Horn, Thibaud Lebouvier, Ali Amad
BACKGROUND: Catatonia is a highly prevalent syndrome in patients presenting with major neurocognitive disorders (dementia). In this study, we aim to provide a comprehensive description of the clinical and therapeutic aspects of catatonia in patients with dementia. METHOD: This descriptive study, conducted between September 2015 and June 2022, collected data from 25 patients diagnosed with dementia, out of 143 patients treated for catatonia in our specialized psychiatry department...
March 27, 2024: Asian Journal of Psychiatry
https://read.qxmd.com/read/38562616/association-of-parkinson-s-disease-to-parkinson-s-plus-syndromes-lewy-body-dementia-and-alzheimer-s-dementia
#35
REVIEW
Priyadarshi Prajjwal, Nikhil Deep Kolanu, Yeruva Bheemeswara Reddy, Aneeqa Ahmed, Mohammed Dheyaa Marsool Marsool, Krupanagram Santoshi, Himani Harshad Pattani, Jobby John, Kiran Kishor Chandrasekar, Omniat Amir Hussin
BACKGROUND: Parkinson's disease (PD) is a condition that affects movement and is usually seen in those over the age of 50. It is caused by the death of dopaminergic neurons, particularly in the substantia nigra. PD has shifted from being perceived as an uncommon condition to a significant neurological illness, mostly due to the increasing number of elderly individuals and the impact of environmental factors. Parkinson's plus syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and vascular Parkinsonism (VaP), provide difficulties in distinguishing them clinically from PD since they have similar characteristics...
April 2024: Health Science Reports
https://read.qxmd.com/read/38560320/philosophies-and-surgical-techniques-for-ewing-s-sarcoma-of-spine-with-review-of-literature
#36
JOURNAL ARTICLE
Rajendra Sakhrekar, Carlo Iorio, Samuel Yoon, Maria Pia Monjardino, Stephen Lewis, Randolph Gray
INTRODUCTION: Ewing sarcoma (ES) is a malignant and aggressive bony tumor affecting the most common age group of 5-20 years. It constitutes 10%-15% of all bone sarcomas and is the second most common primary malignant bone tumor after osteosarcoma. It usually presents with pain, which is typically constant and progressive in nature. The primary source of pain is due to the instability of the spine to support the weight of the body, the vertebral body's expanding cortices due to the growing mass, compression of nerve roots due to tumour mass, pathologic fractures, spinal cord compression, and invasion of tissue by the tumour mass...
March 2024: Journal of Orthopaedic Case Reports
https://read.qxmd.com/read/38554485/a-neuroimaging-measure-to-capture-heterogeneous-patterns-of-atrophy-in-parkinson-s-disease-and-dementia-with-lewy-bodies
#37
JOURNAL ARTICLE
R Bhome, S Verdi, S A Martin, N Hannaway, I Dobreva, N P Oxtoby, G Castro Leal, S Rutherford, A F Marquand, R S Weil, J H Cole
INTRODUCTION: Parkinson's disease (PD) and Dementia with Lewy bodies (DLB) show heterogeneous brain atrophy patterns which group-average analyses fail to capture. Neuroanatomical normative modelling overcomes this by comparing individuals to a large reference cohort. Patient-specific atrophy patterns are measured objectively and summarised to index overall neurodegeneration (the 'total outlier count'). We aimed to quantify patterns of neurodegenerative dissimilarity in participants with PD and DLB and evaluate the potential clinical relevance of total outlier count by testing its association with key clinical measures in PD and DLB...
March 21, 2024: NeuroImage: Clinical
https://read.qxmd.com/read/38553463/structure-of-alpha-synuclein-fibrils-derived-from-human-lewy-body-dementia-tissue
#38
JOURNAL ARTICLE
Dhruva D Dhavale, Alexander M Barclay, Collin G Borcik, Katherine Basore, Deborah A Berthold, Isabelle R Gordon, Jialu Liu, Moses H Milchberg, Jennifer Y O'Shea, Michael J Rau, Zachary Smith, Soumyo Sen, Brock Summers, John Smith, Owen A Warmuth, Richard J Perrin, Joel S Perlmutter, Qian Chen, James A J Fitzpatrick, Charles D Schwieters, Emad Tajkhorshid, Chad M Rienstra, Paul T Kotzbauer
The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. Here we develop and validate a method to amplify Asyn fibrils extracted from LBD postmortem tissue samples and use solid state nuclear magnetic resonance (SSNMR) studies to determine atomic resolution structure. Amplified LBD Asyn fibrils comprise a mixture of single protofilament and two protofilament fibrils with very low twist. The protofilament fold is highly similar to the fold determined by a recent cryo-electron microscopy study for a minority population of twisted single protofilament fibrils extracted from LBD tissue...
March 29, 2024: Nature Communications
https://read.qxmd.com/read/38550413/cognitive-impairment-in-a-64-year-old-male-dilemmas-with-differential-diagnosis-for-patients-with-dementia
#39
Eduardo D Espiridion, Noorvir Kaur
Dementia is characterized by cognitive impairment and difficulties in executive functioning. It is an umbrella term for different subtypes that should be differentiated using a meticulous review of the patient's history, physical exam, and work-up. Posing difficulties in diagnosis, findings at times may be inconclusive. We report a case of a depressed patient on hemodialysis for end-stage renal disease (ESRD) who presents with an acute agitated episode following a visual hallucination that he has been experiencing intermittently for six months, along with a three- to four-year history of cognitive impairments...
February 2024: Curēus
https://read.qxmd.com/read/38549630/retinal-and-cortical-visual-processing-dysfunction-in-a-case-of-mild-cognitive-impairment-with-lewy-bodies-a-case-report
#40
Giulia Perini, Matteo Cotta Ramusino, Francesca Conca, Giuseppe Cosentino, Lisa Maria Farina, Alfredo Costa, Elisabetta Farina
The prodromal stage of Lewy body dementia includes a mild cognitive impairment with visual processing and/or attention-executive deficits. A clinical presentation with progressive visual loss is indeed seldom reported and can be misleading with a posterior cortical atrophy disease. While the neurodegeneration at the occipital cortex can only partially explain the visual disturbances of Lewy body dementia, more recently a retinal dysfunction has been suggested by preliminary optical coherence tomography and autoptic findings...
2024: JAD Reports
keyword
keyword
29092
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.